Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain

Drugs of the Future

Volumn 28, Issue 8, 2003, Pages 787-795

  Planells Cases, Rosa ^a   García Martínez, Carolina ^a   Royo, Miriam ^b   Pérez Payá, Enrique ^c   Carreño, Crístina ^d   Albericio, Fernando ^b   Messeguer, Angel ^c   Ferrer Montiel, Antonio ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^d DiverDrugs   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANANDAMIDE; ARVANIL; CAPSAICIN DERIVATIVE; CAPSAICINOID DERIVATIVE; CAPSAZEPINE; DD 161515; DD 191515; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N [2 [2 (N METHYL 2 PYRROLIDINYL)ETHYL]GLYCYL N (2,4 DICHLOROPHENETHYL)GLYCYL N (2,4 DICHLOROPHENETHYL)GLYCINAMIDE]; N [3 (N,N DIETHYLAMINO)PROPYL GLYCYL N (2,4 DICHLOROPHENETHYL)GLYCYL N 2,4 DICHLOROPHENETHYL)GLYCINAMIDE]; N ARACHIDONOYL DOPAMINE; OLVANIL; RESINIFERATOXIN; RUTHENIUM RED; SCUTIGERAL; SDZ 249482; SDZ 249665; TRANSIENT RECEPTOR POTENTIAL V1 RECEPTOR; TRANSIENT RECEPTOR POTENTIAL V1 RECEPTOR AGONIST; TRANSIENT RECEPTOR POTENTIAL V1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VANILLOID DERIVATIVE; VANILLOID RECEPTOR;

ANALGESIC ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HYPERALGESIA; INFLAMMATION; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PROPRIOCEPTION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

EID: 0242386586     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2003.028.08.747395     Document Type: Review

References (41)

1. Russo, C.M., Brose, W.G. Chronic pain. Annu Rev Med 1998, 49: 123-33.
2. Woolf, C.J., Salter, M.W. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288: 1765-8.
3. Brower, V. New paths to pain relief. Nat Biotech 2000, 18: 387-91.
4. Williams, M., Kowaluk, E.A., Arneric, S.P. Emerging molecular approaches to pain therapy. J Med Chem 1999, 42: 1481-500.
5. McCleskey, E.W., Gold, M.S. Ion channels of nociception. Annu Rev Physiol 1999, 61: 835-56.
6. Cesare, P., McNaughton, P. Peripheral pain mechanisms. Curr Opin Neurobiol 1997, 7: 493-9.
7. Wood, J.N., Docherthy, R. Chemical activators of sensory neurons. Rev Physiol 1997, 59; 457-82.
8. Malmberg, A.B., Chen, C., Susumu, T., Basbaum, A.I. Preserved acute pain and reduced neuropathic pain in mice lacking PKC? Science 1997, 278: 279-83.
9. Cui, M., Nicoll, G.D. Cyclic AMP mediates the prostaglandin E2-induced potentiation of bradykinin excitation in rat sensory neurons. Neuroscience 1995, 66: 459-66.
10. Caterina, M.J., Julius, D. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24: 487-517.
11. Willis, W.D. Role of neurotransmitters in sensitization of pain responses. Ann NY Acad Sci 2001, 933: 142-56.
12. Montell, C., Birnbaumer, L., Flockerzi, V. The TRP channels, a remarkably functional family. Cell 2002, 108: 595-8.
13. Stowers, L., Holy, T.E., Meister, M., Dulac, C., Koentges, G. Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science 2002, 295: 1493-500.
14. Minke, B., Cook, B. TRP channel proteins and signal transduction. Physiol Rev 2002, 82: 429-72.
15. Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D., Julius, D. The capsaicin receptor: A heat-activated channel in the pain pathway. Nature 1997, 389: 816-24.
16. Peier, M.A., Reeve, A.J., Andersson, D.A. et al. Heat-sensitive TRP channel expressed in keratinocytes. Science 2002, 296: 2046-9.
17. Holzer, P. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991, 43: 143-201.
18. Tominaga, M., Caterina, M.J., Malmberg, A.B. et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21: 531-43.
19. Guo, A., Vulchanova, L., Wang, J., Li, X., Elde, R. Immunocytochemical localization of the vanilloid receptor (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 1999, 11: 946-58.
20. Mezey, E., Tóth, Z.E., Cortright, D.N. et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000, 97: 3655-60.
21. Birder, L., Kanai, A.J., de Groat, W.C. et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001, 98: 13396-401.
22. Inoue, K., Koizumi, S., Fuziwara, S., Denda, S., Inoue, K., Denda, M. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 2002, 291: 124-9.
23. Avelino, A., Cruz, C., Nagy, I., Cruz, F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002, 109: 787-98.
24. Sian, I., Helena, C., Scott, F., James, I.F., Andrew, S., Rice, C. The capsaicin analogue SDZ249-665 attenuates the hyperreflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder. Pain 2001, 89: 229-35.
25. Rigoni, M., Trevisani, M., Gazzieri, D. et al. Neurogenic responses mediated by vanilloid receptor- 1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxin. Br J Pharmacol 2003, 138: 977-85.
26. Caterina, M.J., Leffler, A., Malmberg, A.B. et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288: 306-13.
27. Davis, J.B., Gray, J., Gunthorpe, M.J. et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405: 183-7.
28. García-Martínez, C., Humet, M., Planells-Cases, R. et al. Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci USA 2002, 99: 2374-9.
29. Szallasi, A., Blumberg, P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51: 159-212.
30. Jung, J., Hwang, S.W., Kwak, J. et al. Capsaicin binds to the intracellular domain of the capsaicin activated ion channel. J Neurosci 1999, 19: 529-38.
31. Jordt, S.E., Julius, D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 2002, 108: 421-30.
32. Di Marzo, V., Blumberg, P.M., Szallasi, A. Endovanilloid signaling in pain. Curr Opin Neurobiol 2002, 12: 372-9.
33. Zymunt, P.M., Peterson, J., Anderson, D.A. et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999, 400: 452-7.
34. Hwang, S.W., Kwak, J., Wang, M.H. et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000, 97: 6155-60.
35. Huang, S.M., Bisogno, T., Trevisani, M. et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002, 99: 8400-5.
36. Park, H., Park M., Choi, J. et al. Synthesis of N,N,′N″ -trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor. Bioorg Med Chem Lett 2003, 13: 601-4.
37. Wahl, P., Foged, C., Tullin, S., Thomsen, C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 2001, 59: 9-15.
38. Planells-Cases, R., Aracil, A., Merino, J. et al. Arginine rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett 2000, 481: 131-6.
39. 2+ imaging study in adult rat dorsal root ganglion neurons. J Pharmacol Exp Ther 2002, 301: 981-6.
40. Boden, P., Eden, J.M., Hodgson, J. et al. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. J Med Chem 1996, 39, 1664-75.
41. Di Marzo, V., Bisogno, T., De Petrocellis, L. et al. Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands. Biochem Biophys Res Commun 2001, 281: 444-51.